|
GB0003154D0
(en)
*
|
2000-02-12 |
2000-04-05 |
Astrazeneca Uk Ltd |
Novel compounds
|
|
EP2363396A1
(en)
*
|
2001-06-11 |
2011-09-07 |
Virochem Pharma Inc. |
Thiophene derivatives as antiviral agents for flavivirus infection
|
|
SE0102616D0
(sv)
*
|
2001-07-25 |
2001-07-25 |
Astrazeneca Ab |
Novel compounds
|
|
TW200403991A
(en)
|
2002-04-11 |
2004-03-16 |
Smithkline Beecham Corp |
NF-κb inhibitors
|
|
US7375131B2
(en)
*
|
2002-06-06 |
2008-05-20 |
Smithklinebeecham Corp. |
NF-κB inhibitors
|
|
SE0202279D0
(sv)
*
|
2002-07-19 |
2002-07-19 |
Astrazeneca Ab |
Novel comppounds
|
|
SE0202280D0
(sv)
*
|
2002-07-19 |
2002-07-19 |
Astrazeneca Ab |
Novel compounds
|
|
EP1556053A4
(en)
|
2002-10-31 |
2006-04-19 |
Amgen Inc |
ANTI-INFLAMMATORY AGENTS
|
|
WO2004053087A2
(en)
*
|
2002-12-06 |
2004-06-24 |
Smithkline Beecham Corporation |
Nf-κb inhibitors
|
|
DE60332482D1
(de)
|
2002-12-10 |
2010-06-17 |
Virochem Pharma Inc |
Verbindungen und methoden zum behandeln oder vorbeugen von flavivirus infektionen
|
|
SE0300092D0
(sv)
*
|
2003-01-15 |
2003-01-15 |
Astrazeneca Ab |
Novel compounds
|
|
SE0300091D0
(sv)
*
|
2003-01-15 |
2003-01-15 |
Astrazeneca Ab |
Novel compounds
|
|
ES2314443T3
(es)
|
2003-08-15 |
2009-03-16 |
Astrazeneca Ab |
Tiofenos sustituidos y sus usos.
|
|
WO2005056562A1
(en)
*
|
2003-12-05 |
2005-06-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxylic acid amide compounds as ikk inhibitors
|
|
JP2007517843A
(ja)
*
|
2004-01-05 |
2007-07-05 |
アストラゼネカ アクチボラグ |
Chk1阻害剤であるチオフェン誘導体
|
|
GB0402809D0
(en)
*
|
2004-02-09 |
2004-03-10 |
Glaxo Group Ltd |
Chemical compounds
|
|
TW200609237A
(en)
*
|
2004-04-12 |
2006-03-16 |
Sankyo Co |
Thienopyridine derivatives
|
|
JP5117374B2
(ja)
|
2005-03-29 |
2013-01-16 |
イコス・コーポレイション |
Chk1阻害に有用なヘテロアリール尿素誘導体
|
|
JP5030947B2
(ja)
*
|
2005-05-13 |
2012-09-19 |
ヴァイロケム・ファーマ・インコーポレーテッド |
フラビウイルス感染の治療及び予防のための化合物及び方法
|
|
WO2007097981A2
(en)
|
2006-02-16 |
2007-08-30 |
Millennium Pharmaceuticals, Inc. |
Alpha carbolines and uses thereof
|
|
SG176488A1
(en)
*
|
2006-11-15 |
2011-12-29 |
Virochem Pharma Inc |
Thiophene analogues for the treatment or prevention of flavivirus infections
|
|
WO2009132050A2
(en)
|
2008-04-21 |
2009-10-29 |
Otonomy, Inc. |
Auris formulations for treating otic diseases and conditions
|
|
US11969501B2
(en)
|
2008-04-21 |
2024-04-30 |
Dompé Farmaceutici S.P.A. |
Auris formulations for treating otic diseases and conditions
|
|
JP2010006717A
(ja)
*
|
2008-06-24 |
2010-01-14 |
Kyorin Pharmaceut Co Ltd |
ジヒドロチエノ[2,3−e]インダゾール化合物
|
|
EP2366699B1
(en)
|
2008-10-02 |
2013-08-07 |
Asahi Kasei Pharma Corporation |
8-substituted isoquinoline derivative and use thereof
|
|
US20100135984A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Anti-inflammatory compositions and methods
|
|
US20100136094A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems for modulating inflammation
|
|
US20100136096A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems for modulating inflammation
|
|
US20100135983A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Anti-inflammatory compositions and methods
|
|
US20100137246A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Anti-inflammatory compositions and methods
|
|
US20100135908A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Delivery devices for modulating inflammation
|
|
US20100136095A1
(en)
*
|
2008-12-02 |
2010-06-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Systems for modulating inflammation
|
|
WO2011077502A1
(ja)
*
|
2009-12-21 |
2011-06-30 |
杏林製薬株式会社 |
ジヒドロチエノ[2,3-e]インダゾール化合物
|
|
EP2520292A1
(en)
|
2011-05-06 |
2012-11-07 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Use of spirangiens for the treatment or prevention of IL-8 or IL-6 mediated disorders
|
|
EP2898102A4
(en)
|
2012-09-20 |
2016-05-18 |
Univ Emory |
CLASSIFIERS OF NF-KB-PFADAKTIVIERUNG AND DEVICES AND METHODS OF USE THEREOF
|
|
EP3478269A4
(en)
|
2016-06-29 |
2020-04-08 |
Otonomy, Inc. |
OTIC FORMULATIONS BASED ON TRIGLYCERIDES AND THEIR USES
|
|
WO2019012159A1
(en)
|
2017-07-14 |
2019-01-17 |
Protea Biopharma N.V. |
METHODS AND MEANS FOR DIAGNOSING AND / OR TREATING A FATIGUE-ASSOCIATED DISEASE
|
|
ES3011633T3
(en)
|
2017-08-31 |
2025-04-07 |
Ahammune Biosciences Private Ltd |
Thiophene compounds, process for synthesis and use thereof for the treatment of autoimmune disorders
|
|
CN115161289B
(zh)
*
|
2022-03-14 |
2023-12-05 |
东南大学 |
一种用于炎症性疾病治疗的重组腺相关病毒及其构建方法和应用
|